The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Plasma Volume

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Plasma Volume


Psychiatry related information on Plasma Volume


High impact information on Plasma Volume


Chemical compound and disease context of Plasma Volume


Biological context of Plasma Volume


Anatomical context of Plasma Volume


Associations of Plasma Volume with chemical compounds


Gene context of Plasma Volume


Analytical, diagnostic and therapeutic context of Plasma Volume

  • CONCLUSIONS: The reduction of plasma renin activity, plasma aldosterone, and arginine vasopressin occurred earlier than the reduction of plasma volume and atrial natriuretic peptide after HeartMate implantation, possibly because of decreased pulmonary congestion and improved renal perfusion [34].
  • Gel filtration of human platelet-rich plasma (PRP) on columns of Sepharose 2B removed at least 99.85% of the plasma proteins from platelets when a column 10 cm in height was used and a plasma volume 11 to 14% of the gel-bed volume was applied [35].
  • METHODS: Plasma volume and fluid regulatory hormones were measured in eight HTRs (57+/-6 years old) both before and after treatment with captopril (225 mg/day) [36].
  • In both patients, the activity of vWF-cleaving protease after the first plasmapheresis session was evaluated and was found to be virtually identical to anticipated activity calculated from predicted patient plasma volume and volume of exchanged plasma [37].
  • Apheresis of 125% of the calculated plasma volume decreased plasma LDL-cholesterol by 69% to 0.9 +/- 0.2 mmol/l, with significant increases in plasma MVA and L/C ratio on the day after the procedure [38].


  1. The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. Watkins, L., Burton, J.A., Haber, E., Cant, J.R., Smith, F.W., Barger, A.C. J. Clin. Invest. (1976) [Pubmed]
  2. Circulating levels of endothelin in cirrhosis. Asbert, M., Ginès, A., Ginès, P., Jiménez, W., Clària, J., Saló, J., Arroyo, V., Rivera, F., Rodés, J. Gastroenterology (1993) [Pubmed]
  3. Volume-pressure relationships during development of mineralocorticoid hypertension in man. Wenting, G.H., Man in 't Veld, A.J., Verhoeven, R.P., Derkx, F.H., Schalekamp, D.H. Circ. Res. (1977) [Pubmed]
  4. Dual role for nitric oxide in the regulation of plasma volume and albumin escape during endotoxin shock in conscious rats. Filep, J.G., Delalandre, A., Beauchamp, M. Circ. Res. (1997) [Pubmed]
  5. Renal and systemic hemodynamic responses to intravenous infusion of leukotriene C4 in the rat. Badr, K.F., Baylis, C., Pfeffer, J.M., Pfeffer, M.A., Soberman, R.J., Lewis, R.A., Austen, K.F., Corey, E.J., Brenner, B.M. Circ. Res. (1984) [Pubmed]
  6. Conservation of blood plasma fluids in hamadryas baboons after thermal dehydration. Zurovsky, Y., Shkolnik, A., Ovadia, M. Journal of applied physiology: respiratory, environmental and exercise physiology. (1984) [Pubmed]
  7. Treatment of orthostatic hypotension with erythropoietin. Hoeldtke, R.D., Streeten, D.H. N. Engl. J. Med. (1993) [Pubmed]
  8. Evidence of an endogenous digitalis-like factor in the plasma of patients with acromegaly. Deray, G., Rieu, M., Devynck, M.A., Pernollet, M.G., Chanson, P., Luton, J.P., Meyer, P. N. Engl. J. Med. (1987) [Pubmed]
  9. How carbon monoxide reduces plasma volume. Stonesifer, L.D. N. Engl. J. Med. (1978) [Pubmed]
  10. Psychotherapeutic control of hypertension. Stone, R.A., DeLeo, J. N. Engl. J. Med. (1976) [Pubmed]
  11. Nicotinic acid reduction of plasma volume loss after thermal trauma. Hilton, J.G., Wells, C.H. Science (1976) [Pubmed]
  12. A simplified single stage total hepatectomy in the rat with maintenance of gastrointestinal absorptive function. Yamaguchi, Y., Bollinger, R.R., DeFaria, E., Landis, B., Quarfordt, S. Hepatology (1989) [Pubmed]
  13. Volume depletion and natriuresis in patients with a ruptured intracranial aneurysm. Wijdicks, E.F., Vermeulen, M., ten Haaf, J.A., Hijdra, A., Bakker, W.H., van Gijn, J. Ann. Neurol. (1985) [Pubmed]
  14. N omega-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats. Lee, F.Y., Colombato, L.A., Albillos, A., Groszmann, R.J. Hepatology (1993) [Pubmed]
  15. Endotoxin-induced ascites formation in the rat: partial mediation by platelet-activating factor. Guarner, F., Wallace, J.L., MacNaughton, W.K., Ibbotson, G.C., Arroyo, V., Rodés, J. Hepatology (1989) [Pubmed]
  16. Acetaminophen-induced hepatotoxic congestion in mice. Walker, R.M., Racz, W.J., McElligott, T.F. Hepatology (1985) [Pubmed]
  17. Interaction between alpha 2-adrenergic and angiotensin II systems in the control of glomerular hemodynamics as assessed by renal micropuncture in the rat. Thomson, S.C., Gabbai, F.B., Tucker, B.J., Blantz, R.C. J. Clin. Invest. (1992) [Pubmed]
  18. Atrial natriuretic peptide: an essential physiological regulator of transvascular fluid, protein transport, and plasma volume. Curry, F.R. J. Clin. Invest. (2005) [Pubmed]
  19. A renal abnormality as a possible cause of "essential" hypertension. Bianchi, G., Cusi, D., Gatti, M., Lupi, G.P., Ferrari, P., Barlassina, C., Picotti, G.B., Bracchi, G., Colombo, G., Gori, D., Velis, O., Mazzei, D. Lancet (1979) [Pubmed]
  20. Quantitative aspects of bilirubin metabolism for hematologists. Berlin, N.I., Berk, P.D. Blood (1981) [Pubmed]
  21. Decreased expression of Kv4.2 and novel Kv4.3 K+ channel subunit mRNAs in ventricles of renovascular hypertensive rats. Takimoto, K., Li, D., Hershman, K.M., Li, P., Jackson, E.K., Levitan, E.S. Circ. Res. (1997) [Pubmed]
  22. Renin-angiotensin-aldosterone system in diabetes mellitus. Christlieb, A.R. Diabetes (1976) [Pubmed]
  23. Normal renin uremic hypertension. Study of cardiac hemodynamics, plasma volume, extracellular fluid volume, and the renin angiotensin system. Cangiano, J.L., Ramirez-Muxó, O., Ramirez-Gonzalez, R., Trevino, A., Campos, J.A. Arch. Intern. Med. (1976) [Pubmed]
  24. Role of prostaglandins in the pathogenesis of Bartter's syndrome. Fichman, M.P., Telfer, N., Zia, P., Speckart, P., Golub, M., Rude, R. Am. J. Med. (1976) [Pubmed]
  25. Blood volume and body fluid compartments in lambs with aortopulmonary left-to-right shunts. Gratama, J.W., Dalinghaus, M., Meuzelaar, J.J., Gerding, A.M., Koers, J.H., Zijlstra, W.G., Kuipers, J.R. J. Clin. Invest. (1992) [Pubmed]
  26. Continuous noninvasive monitoring of pH and temperature in rat Walker 256 carcinoma during normoglycemia and hyperglycemia. Jain, R.K., Shah, S.A., Finney, P.L. J. Natl. Cancer Inst. (1984) [Pubmed]
  27. Evidence that patients with Addison's disease are undertreated with fludrocortisone. Smith, S.J., MacGregor, G.A., Markandu, N.D., Bayliss, J., Banks, R.A., Prentice, M.G., Dorrington-Ward, P., Wise, P. Lancet (1984) [Pubmed]
  28. Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin. Kochar, M.S., Itskovitz, H.D. Lancet (1978) [Pubmed]
  29. Antidiuretic action of vasopressin: quantitative aspects and interaction between V1a and V2 receptor-mediated effects. Bankir, L. Cardiovasc. Res. (2001) [Pubmed]
  30. Reactivity of plasma glutathione peroxidase with hydroperoxide substrates and glutathione. Esworthy, R.S., Chu, F.F., Geiger, P., Girotti, A.W., Doroshow, J.H. Arch. Biochem. Biophys. (1993) [Pubmed]
  31. In vivo effects of interleukin-11 and stem cell factor in combination with erythropoietin in the regulation of erythropoiesis. de Haan, G., Dontje, B., Engel, C., Loeffler, M., Nijhof, W. Br. J. Haematol. (1995) [Pubmed]
  32. Measuring plasminogen activator inhibitor activity in plasma by two enzymatic assays. Chiu, W.C., Gann, D.S., Darlington, D.N. J. Biochem. Biophys. Methods (2000) [Pubmed]
  33. Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Souza-Tarla, C.D., Uzuelli, J.A., Machado, A.A., Gerlach, R.F., Tanus-Santos, J.E. Clin. Biochem. (2005) [Pubmed]
  34. Plasma volume and its regulatory factors in congestive heart failure after implantation of long-term left ventricular assist devices. James, K.B., McCarthy, P.M., Jaalouk, S., Bravo, E.L., Betkowski, A., Thomas, J.D., Nakatani, S., Fouad-Tarazi, F.M. Circulation (1996) [Pubmed]
  35. Gel-filtered human platelets. Ultrastructure, function, and role of proteins in inhibition of aggregation by aspirin. Fine, K.M., Ashbrook, P.C., Brigden, L.P., Maldonado, J.E., Didishelm, P. Am. J. Pathol. (1976) [Pubmed]
  36. High dose angiotensin-converting enzyme inhibition prevents fluid volume expansion in heart transplant recipients. Braith, R.W., Mills, R.M., Wilcox, C.S., Mitchell, M.J., Hill, J.A., Wood, C.E. J. Am. Coll. Cardiol. (2000) [Pubmed]
  37. Recovery and half-life of von Willebrand factor-cleaving protease after plasma therapy in patients with thrombotic thrombocytopenic purpura. Furlan, M., Robles, R., Morselli, B., Sandoz, P., Lämmle, B. Thromb. Haemost. (1999) [Pubmed]
  38. Upregulation of cholesterol synthesis after acute reduction of low density lipoprotein by apheresis in normocholesterolaemic subjects: evidence for a threshold effect. Pfohl, M., Naoumova, R.P., Neuwirth, C., Sussekov, A., Smykowski, J., Rendell, N.B., Taylor, G.W., Seif, F.J., Thompson, G.R. Atherosclerosis (1997) [Pubmed]
WikiGenes - Universities